Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simona Rolla

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Expert Opinion on Drug Safety|June 23, 2017
Long-term safety evaluation of natalizumab for the treatment of multiple sclerosisMarinella Clerico, Carlo Alberto Artusi, Alessandra Di Liberto, et al.
Journal of Leukocyte Biology|August 7, 2014
Th22 cells are expanded in multiple sclerosis and are resistant to IFN-βSimona Rolla, Valentina Bardina, Stefania De Mercanti, et al.
International Immunology|January 18, 2006
Mycobacterium tuberculosis in the adjuvant modulates the balance of Th immune response to self-antigen of the CNS without influencing a "core" repertoire of specific T cellsChiara Nicolò, Gabriele Di Sante, Massimiliano Orsini, et al.
Human Gene Therapy|February 14, 2008
Protective immunity against neu-positive carcinomas elicited by electroporation of plasmids encoding decreasing fragments of rat neu extracellular domainSimona Rolla, Cristina Marchini, Silvia Malinarich, et al.
Frontiers in Immunology|March 26, 2021
Immune Trait Shifts in Association With Tobacco Smoking: A Study in Healthy WomenGiulia Piaggeschi, Simona Rolla, Niccolò Rossi, et al.
Cancer Immunology, Immunotherapy : CII|February 4, 2005
Immune prevention of mammary carcinogenesis in HER-2/neu transgenic mice: a microarray scenarioAnnalisa Astolfi, Simona Rolla, Patrizia Nanni, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 4, 2010
Erbb2 DNA vaccine combined with regulatory T cell deletion enhances antibody response and reveals latent low-avidity T cells: potential and limits of its therapeutic efficacySimona Rolla, Francesco Ria, Sergio Occhipinti, et al.
Journal of Neuroimmunology|November 21, 2017
Lack of CD4+ T cell percent decrease in alemtuzumab-treated multiple sclerosis patients with persistent relapsesSimona Rolla, Stefania Federica De Mercanti, Valentina Bardina, et al.
Oncotarget|April 11, 2015
Targeting of surface alpha-enolase inhibits the invasiveness of pancreatic cancer cellsMoitza Principe, Patrizia Ceruti, Neng-Yao Shih, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 29, 2016
Alemtuzumab long-term immunologic effect: Treg suppressor function increases up to 24 monthsStefania De Mercanti, Simona Rolla, Angele Cucci, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Expert Opinion on Drug Safety|June 23, 2017
Long-term safety evaluation of natalizumab for the treatment of multiple sclerosisMarinella Clerico, Carlo Alberto Artusi, Alessandra Di Liberto, et al.
Journal of Leukocyte Biology|August 7, 2014
Th22 cells are expanded in multiple sclerosis and are resistant to IFN-βSimona Rolla, Valentina Bardina, Stefania De Mercanti, et al.
International Immunology|January 18, 2006
Mycobacterium tuberculosis in the adjuvant modulates the balance of Th immune response to self-antigen of the CNS without influencing a "core" repertoire of specific T cellsChiara Nicolò, Gabriele Di Sante, Massimiliano Orsini, et al.
Human Gene Therapy|February 14, 2008
Protective immunity against neu-positive carcinomas elicited by electroporation of plasmids encoding decreasing fragments of rat neu extracellular domainSimona Rolla, Cristina Marchini, Silvia Malinarich, et al.
Frontiers in Immunology|March 26, 2021
Immune Trait Shifts in Association With Tobacco Smoking: A Study in Healthy WomenGiulia Piaggeschi, Simona Rolla, Niccolò Rossi, et al.
Cancer Immunology, Immunotherapy : CII|February 4, 2005
Immune prevention of mammary carcinogenesis in HER-2/neu transgenic mice: a microarray scenarioAnnalisa Astolfi, Simona Rolla, Patrizia Nanni, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 4, 2010
Erbb2 DNA vaccine combined with regulatory T cell deletion enhances antibody response and reveals latent low-avidity T cells: potential and limits of its therapeutic efficacySimona Rolla, Francesco Ria, Sergio Occhipinti, et al.
Journal of Neuroimmunology|November 21, 2017
Lack of CD4+ T cell percent decrease in alemtuzumab-treated multiple sclerosis patients with persistent relapsesSimona Rolla, Stefania Federica De Mercanti, Valentina Bardina, et al.
Oncotarget|April 11, 2015
Targeting of surface alpha-enolase inhibits the invasiveness of pancreatic cancer cellsMoitza Principe, Patrizia Ceruti, Neng-Yao Shih, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 29, 2016
Alemtuzumab long-term immunologic effect: Treg suppressor function increases up to 24 monthsStefania De Mercanti, Simona Rolla, Angele Cucci, et al.
Pageof 4